Clinical Trials Browser

Phase NA × Hematologic Neoplasms × Therapeutics × Clear all

NCT06373471 2024-04-18

IMPROVE

Phase NA Recruiting

Other hematologic neoplasm

Frailty, Treatment Adherence and Compliance, Hematologic Neoplasms